| What should we do about student use of cognitive enhancers? An analysis of current evidence CI Ragan, I Bard, I Singh Neuropharmacology 64, 588-595, 2013 | 211 | 2013 |
| Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland I Singh, I Bard, J Jackson PloS one 9 (10), e105969, 2014 | 202 | 2014 |
| Voice of the psychonauts: Coping, life purpose, and spirituality in psychedelic drug users L Móró, K Simon, I Bárd, J Rácz Journal of psychoactive drugs 43 (3), 188-198, 2011 | 131 | 2011 |
| Public views on gene editing and its uses G Gaskell, I Bard, A Allansdottir, RV Da Cunha, P Eduard, J Hampel, ... Nature biotechnology 35 (11), 1021-1023, 2017 | 114 | 2017 |
| Globalization and cognitive enhancement: emerging social and ethical challenges for ADHD clinicians I Singh, AM Filipe, I Bard, M Bergey, L Baker Current psychiatry reports 15, 1-9, 2013 | 108 | 2013 |
| Bottom Up Ethics - Neuroenhancement in Education and Employment I Bard, G Gaskell, A Allansdottir, RV da Cunha, P Eduard, J Hampel, ... Neuroethics 11 (3), 309-322, 2018 | 26 | 2018 |
| Neuroenhancements in the military: A mixed-method pilot study on attitudes of staff officers to ethics and rules S Sattler, E Jacobs, I Singh, D Whetham, I Bárd, J Moreno, G Galeazzi, ... Neuroethics 15 (1), 11, 2022 | 8 | 2022 |
| The Doubtful Chances of Choice I Bard Frontiers of Cyberspace, 2012 | 6 | 2012 |
| Attention Deficit Hyperactivity Disorder: Improving Performance Through Brain–Computer Interface I Bárd, I Singh Handbook of Neuroethics, pp 741-762, 2014 | 5 | 2014 |
| Ethical Dimensions of Commercial and DIY Neurotechnologies I Bárd, E Hildt | 4 | 2020 |
| Pre-empting the Threat of Human Deficiencies I Bard Neoliberalism and Technoscience. Critical Assessments, 139-161, 2012 | 4* | 2012 |
| Regulator approaches to facilitate, support and enable innovation H Armstrong, I Bárd, E Engström BEIS Research Paper series number 2020/003, 2020 | 3 | 2020 |
| Tailoring reality—The ethics of DIY and consumer sensory enhancement I Bárd Ethical Dimensions of Commercial and DIY Neurotechnologies 3, 93-125, 2020 | 2 | 2020 |
| Troubles with Posthumanism I Bard na, 2010 | 2 | 2010 |
| Help to survey the use of smart drugs I Bard, I Singh Nature 486 (7404), 473-473, 2012 | 1 | 2012 |
| The Neuroethics of Decisional Enhancement PB Reiner, SK Nagel, I Bárd The Neuroethics Blog, 2020 | | 2020 |
| Preface: Ethical aspects of DIY and commercial neurotechnologies I Bárd, E Hildt Ethical Dimensions of Commercial and DIY Neurotechnologies 3, xi-xx, 2020 | | 2020 |
| ‘Everyday Enhancement’: Parents and Professionals Making Decisions about Drug Treatment of Minors for Problems with Learning and Behaviour I Bard, I Singh, P Eduard eLS, 2017 | | 2017 |
| What should we do about student use of cognitive enhancers?: An analysis of current evidence (vol 64, pg 588, 2012) CI Ragan, I Bard, I Singh NEUROPHARMACOLOGY 65, 28-28, 2013 | | 2013 |
| Transhumanismus: Selbstentfaltung oder Selbstauflösung? I Bard Ist Technik die Zukunft der menschlichen Natur?, 2012 | | 2012 |
Agnes AllansdottirFondazione Toscana Life Sciences, Complex Systems CommunityDirección de correo verificada de toscanalifesciences.org
